Gossamer Bio (GOSS) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -3.37 | 0.14 | 0.52 | -2.83 | -4.89 | -0.84 | ||
| Changes by years, y/y, % | +129% | -104% | +266% | -645% | +73% | +27.1% | |||
Gossamer Bio. EV/EBITDA
Gossamer Bio. EV/EBITDA, changes, %
Gossamer Bio (GOSS) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -5.44 | -2.10 | -4.26 | -4.84 | -1.07 | -0.84 | |
| Changes by years, y/y, % | -2 491% | -180% | +123% | +71% | -80% | |||
| Changes by quarters, q/q, % | +92% | -62% | +103% | +14% | -78% | |||